These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 25656129)
1. [Screening for predictive biomarkers of bevacizumab treatment in gastric cancer subcutaneous xenografts]. Zhang Q; Xu J; Ye J; Yuan Y; Chen J; Peng J; He Y Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Feb; 18(2):177-80. PubMed ID: 25656129 [TBL] [Abstract][Full Text] [Related]
2. [Impacts of Bevacizumab on vascular endothelial growth factor and Sp1 expression in gastric cancer xenografts]. Zhou CF; Ji J; Yuan F; Yu YY; Liu BY; Zhang J; Zhu ZG Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb; 15(2):180-4. PubMed ID: 22368029 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers for antitumor activity of bevacizumab in gastric cancer models. Yamashita-Kashima Y; Fujimoto-Ouchi K; Yorozu K; Kurasawa M; Yanagisawa M; Yasuno H; Mori K BMC Cancer; 2012 Jan; 12():37. PubMed ID: 22273502 [TBL] [Abstract][Full Text] [Related]
4. Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice. Yagi Y; Fushida S; Harada S; Tsukada T; Kinoshita J; Oyama K; Fujita H; Ninomiya I; Fujimura T; Kayahara M; Kinuya S; Yashiro M; Hirakawa K; Ohta T Cancer Chemother Pharmacol; 2010 Sep; 66(4):745-53. PubMed ID: 20033809 [TBL] [Abstract][Full Text] [Related]
5. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms]. Fan YZ; Chen CQ; Zhao ZM; Sun W Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):693-9. PubMed ID: 16681930 [TBL] [Abstract][Full Text] [Related]
6. Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model. van der Bilt AR; Terwisscha van Scheltinga AG; Timmer-Bosscha H; Schröder CP; Pot L; Kosterink JG; van der Zee AG; Lub-de Hooge MN; de Jong S; de Vries EG; Reyners AK Clin Cancer Res; 2012 Nov; 18(22):6306-14. PubMed ID: 23014526 [TBL] [Abstract][Full Text] [Related]
7. mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft. Inoue S; Hartman A; Branch CD; Bucana CD; Bekele BN; Stephens LC; Chada S; Ramesh R Mol Ther; 2007 Feb; 15(2):287-94. PubMed ID: 17235306 [TBL] [Abstract][Full Text] [Related]
8. [Study of the anti-tumor effect of anti-vascular endothelial growth factor McAb 5-fluorouracil loaded polylactic acid nanoparticles]. Huang KH; Liu JH; Wang LY; Zhu ZH; Chen QK; Min J; Chen RF Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):482-5. PubMed ID: 17851795 [TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effects of luteolin on human gastric carcinoma xenografts in nude mice and its mechanism]. Lu XY; Li YH; Xiao XW; Li XB Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):142-6. PubMed ID: 23648354 [TBL] [Abstract][Full Text] [Related]
10. Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice. Ninomiya S; Inomata M; Tajima M; Ali AT; Ueda Y; Shiraishi N; Kitano S J Surg Res; 2009 Jun; 154(2):196-202. PubMed ID: 19329124 [TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of bevacizumab in combination with capecitabine and oxaliplatin in human colorectal cancer xenograft models. Yanagisawa M; Fujimoto-Ouchi K; Yorozu K; Yamashita Y; Mori K Oncol Rep; 2009 Aug; 22(2):241-7. PubMed ID: 19578762 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma. Gyanchandani R; Sano D; Ortega Alves MV; Klein JD; Knapick BA; Oh S; Myers JN; Kim S Oral Oncol; 2013 Aug; 49(8):761-70. PubMed ID: 23623402 [TBL] [Abstract][Full Text] [Related]
13. Dual targeting of Bcl-2 and VEGF: a potential strategy to improve therapy for prostate cancer. Anai S; Sakamoto N; Sakai Y; Tanaka M; Porvasnik S; Urbanek C; Cao W; Goodison S; Rosser CJ Urol Oncol; 2011; 29(4):421-9. PubMed ID: 19576799 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45. Li H; Adachi Y; Yamamoto H; Min Y; Ohashi H; Ii M; Arimura Y; Endo T; Lee CT; Carbone DP; Imai K; Shinomura Y Cancer; 2011 Jul; 117(14):3135-47. PubMed ID: 21264842 [TBL] [Abstract][Full Text] [Related]
15. [Influence of rosiglitazone and all-trans-retinoic acid on angiogenesis and growth of myeloma xenograft in nude mice]. Huang HW; Chen P; Li BZ; Fu JX; Li J; Zhang XH; Liu R; Fan YY; Zhang H; Chow HC; Leung AY; Liang R Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):652-7. PubMed ID: 23159076 [TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effects of TNP-470 in combination with 5-fluorouracil on growth of human colon cancer]. Fan YF; Huang ZH; Nie J Ai Zheng; 2002 Dec; 21(12):1319-23. PubMed ID: 12520739 [TBL] [Abstract][Full Text] [Related]
17. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice]. Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793 [TBL] [Abstract][Full Text] [Related]
18. Cetuximab reduces the accumulation of radiolabeled bevacizumab in cancer xenografts without decreasing VEGF expression. Heskamp S; Boerman OC; Molkenboer-Kuenen JD; Sweep FC; Geurts-Moespot A; Engelhardt MS; van der Graaf WT; Oyen WJ; van Laarhoven HW Mol Pharm; 2014 Nov; 11(11):4249-57. PubMed ID: 25294389 [TBL] [Abstract][Full Text] [Related]
19. Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model. Iwai T; Sugimoto M; Harada S; Yorozu K; Kurasawa M; Yamamoto K Oncol Rep; 2016 Aug; 36(2):626-32. PubMed ID: 27350037 [TBL] [Abstract][Full Text] [Related]
20. [Abnormal expression of insulin-like growth factor-I receptor and inhibitory effect of its transcription intervention on nude mice xenograft tumor]. Yao M; Yan XD; Cai Y; Gu JJ; Yang XL; Pan LH; Wang L; Yao DF Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):846-851. PubMed ID: 27978931 [No Abstract] [Full Text] [Related] [Next] [New Search]